Last reviewed · How we verify
Otrivin
At a glance
| Generic name | Otrivin |
|---|---|
| Sponsor | Sorlandet Hospital HF |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Oxytocin's Effects on Emotional Processing and Its Acting Routes (NA)
- A Study Comparing Proponent Solution - Nasal Spray (PSNS) With Salt Water for Treating Nasal Congestion Symptoms in Adults With Rebound Nasal Congestion While Weaning From Nasal Decongestant Sprays (NA)
- A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus (PHASE4)
- Get Out of Your Head 2.0: Evaluation of an Online Prevention Campaign and Updated Website for Men (NA)
- Adrenaline Nasal Pack vs Xylometazoline Nasal Drops During Nasotracheal Intubation (PHASE2, PHASE3)
- Cocaine, Lidocaine/xylometazoline and Saline for Nasal Analgesia (PHASE3)
- LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media (NA)
- Otrivine: Quality of Life (QoL) Impact in a Real-World Setting (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Otrivin CI brief — competitive landscape report
- Otrivin updates RSS · CI watch RSS
- Sorlandet Hospital HF portfolio CI